• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Biol Macromol . Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function

tetano

Editor, Senior Moderator
Int J Biol Macromol


. 2021 Dec 1;S0141-8130(21)02556-3.
doi: 10.1016/j.ijbiomac.2021.11.151. Online ahead of print.
Emergence of unique SARS-CoV-2 ORF10 variants and their impact on protein structure and function


Sk Sarif Hassan[SUP] 1 [/SUP], Kenneth Lundstrom[SUP] 2 [/SUP], Ángel Serrano-Aroca[SUP] 3 [/SUP], Parise Adadi[SUP] 4 [/SUP], Alaa A A Aljabali[SUP] 5 [/SUP], Elrashdy M Redwan[SUP] 6 [/SUP], Amos Lal[SUP] 7 [/SUP], Ramesh Kandimalla[SUP] 8 [/SUP], Tarek Mohamed Abd El-Aziz[SUP] 9 [/SUP], Pabitra Pal Choudhury[SUP] 10 [/SUP], Gajendra Kumar Azad[SUP] 11 [/SUP], Samendra P Sherchan[SUP] 12 [/SUP], Gaurav Chauhan[SUP] 13 [/SUP], Murtaza Tambuwala[SUP] 14 [/SUP], Kazuo Takayama[SUP] 15 [/SUP], Debmalya Barh[SUP] 16 [/SUP], Giorgio Palu[SUP] 17 [/SUP], Pallab Basu[SUP] 18 [/SUP], Vladimir N Uversky[SUP] 19 [/SUP]



Affiliations

Abstract

The devastating impact of the ongoing coronavirus disease 2019 (COVID-19) on public health, caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has made targeting the COVID-19 pandemic a top priority in medical research and pharmaceutical development. Surveillance of SARS-CoV-2 mutations is essential for the comprehension of SARS-CoV-2 variant diversity and their impact on virulence and pathogenicity. The SARS-CoV-2 open reading frame 10 (ORF10) protein interacts with multiple human proteins CUL2, ELOB, ELOC, MAP7D1, PPT1, RBX1, THTPA, TIMM8B, and ZYG11B expressed in lung tissue. Mutations and co-occurring mutations in the emerging SARS-CoV-2 ORF10 variants are expected to impact the severity of the virus and its associated consequences. In this article, we highlight 128 single mutations and 35 co-occurring mutations in the unique SARS-CoV-2 ORF10 variants. The possible predicted effects of these mutations and co-occurring mutations on the secondary structure of ORF10 variants and host protein interactomes are presented. The findings highlight the possible effects of mutations and co-occurring mutations on the emerging 140 ORF10 unique variants from secondary structure and intrinsic protein disorder perspectives.

Keywords: And ubiquitin ligase complex; Co-occurring mutations; Intrinsic protein disorder; ORF10; SARS-CoV-2.
 
Back
Top Bottom